+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

mRNA Therapeutics and Vaccines Market, 2020-2030 - Product Thumbnail Image

mRNA Therapeutics and Vaccines Market, 2020-2030

  • Report
  • January 2021
  • 253 Pages
  • Global
From
From
From
From
From
Global Janus Kinase (JAK) Inhibitors Market 2022-2026 - Product Thumbnail Image

Global Janus Kinase (JAK) Inhibitors Market 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
From
From
From
Loading Indicator